Rank 34 • Biotech & Discovery
Insitro
Applies machine learning and high-throughput biology to accelerate drug discovery and development processes.
Visit website- Signal Score
- 89.3
- Total raised
- $643M
- Stage
- Series C
- Founded
- 2018
- Headquarters
- South San Francisco, USA
- Region
- North America
Their signal
Led by industry pioneer Daphne Koller, Insitro uses robust genetic data pipelines and cell-state modeling to identify promising therapeutic targets, representing the pinnacle of data-driven biotech innovation.
Signal Score 89.3editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.